28P Long-term survival and treatment (tx) patterns in patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive (m) advanced NSCLC treated with first-line (1L) osimertinib (osi): German cohort of a global real-world (rw) observational study

F. Griesinger,S. Zacharias, P. Steffens, R. Schuh, P. Hindocha, M. Cooper,J. Chapaneri,R.J-B. Salomonsen, P.S. Karia, M. Thomas

ESMO Open（2024）

Cited 0|Views0

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined